About
Approach
Investment Model
Investment Scope
Our approach
Team
Managing Partner
Partners
Our team
Portfolio
News
Connect
News
Recent news about Panacea Capital and select portfolio companies
January 26, 2026
Interview: Biosimilars, a market reaching an inflection point — a conversation with Frederic Bouvier
January 26, 2026
Interview: Biosimilars, a market reaching an inflection point — a conversation with Frederic Bouvier
January 15, 2026
citybiz – Questions & Answers with Sean A. MacDonald, Chief Executive Officer at Kainova Therapeutics
January 15, 2026
citybiz – Questions & Answers with Sean A. MacDonald, Chief Executive Officer at Kainova Therapeutics
January 15, 2026
Q&A with Sean A. MacDonald, Chief Executive Officer at Kainova Therapeutics
January 15, 2026
Q&A with Sean A. MacDonald, Chief Executive Officer at Kainova Therapeutics
January 12, 2026
Domain Therapeutics Rebrands as Kainova Therapeutics Advancing Its Clinical Pipeline of GPCR-Modulating Therapies
January 12, 2026
Domain Therapeutics Rebrands as Kainova Therapeutics Advancing Its Clinical Pipeline of GPCR-Modulating Therapies
December 10, 2025
Chime Biologics Announces Strategic Collaboration with Beijing Libang Pharmaceutical on Global Blinatumomab Biosimilar Program
December 10, 2025
Chime Biologics Announces Strategic Collaboration with Beijing Libang Pharmaceutical on Global Blinatumomab Biosimilar Program
Previous
15 / 16
Next